Abstract

Clostridium difficile is a serious epidemiological problem and particularly dangerous microorganism causing hospital infections. Currently, the treatment of C. difficile infections is the use of metronidazole or vancomycin. However, in some patients, recurrent infection difficult to treat occurs. Fecal microbiota transplantation (FMT) is a new method used to treat the recurrent CDI. FMT consists in the infusion of the fecal suspension from a healthy donor into the gastrointestinal tract of a patient with CDI to restore the natural intestinal microflora. FMT is safe and effective treatment of recurrent CDI. FMT is extensively described around the world, but to date only two randomized studies confirming the effectiveness of FMT have been conducted. This method was also applied in the treatment of diseases such as pseudomembranous colitis, ulcerative colitis, Crohn’s disease and irritable bowel syndrome. The review describes the procedure for FMT and the current state of knowledge about the effectiveness of FMT in the treatment of recurrent CDI.

References

• 1. Aas J., Gessert C.E., Bakken J.S.: Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis., 2003; 36: 580-585
  Google Scholar
• 2. Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A.: Gastrointestinal flora and gastrointestinal status in children with autismcomparisons to typical children and correlation with autism severity. BMC Gastroenterol., 2011; 11: 22
  Google Scholar
• 3. Ananthaswamy A.: Fecal transplant eases symptoms of Parkinson’s. New Scientist, 2011; 2796: 19
  Google Scholar
• 4. Anderson J.L., Edney R.J., Whelan K.: Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment. Pharmacol. Ther., 2012; 36: 503-516
  Google Scholar
• 5. Andrews P.J, Barnes P., Borody T.J.: Chronic constipation reversed by restoration of the bowel flora. A case and a hypothesis. Eur. J. Gastroenterol. Hepatol., 1992; 4: 245-247
  Google Scholar
• 6. Angelakis E., Armougom F., Million M., Raoult D.: The relationship between gut microbiota and weight gain in humans. Future Microbiol., 2012; 7: 91-109
  Google Scholar
• 7. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., Taniguchi T., Takeda K., Hori S., Ivanov I.I., Umesaki Y., Itoh K., Honda K.: Induction of colonic regulatory T cells by indigenous Clostridium species. Science, 2011; 331: 337-341
  Google Scholar
• 8. Bauer M.P., Veenendaal D., Verhoef L., Bloembergen P., van Dissel J.T., Kuijper E.J.: Clinical and microbiological characteristics of community-onset Clostridium difficile infection in the Netherlands. Clin. Microbiol. Infect., 2009; 15: 1087-1092
  Google Scholar
• 9. Bennet J.D., Brinkman M.: Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet, 1989; 1: 164
  Google Scholar
• 10. Bielec D., Stempkowska J., Markiewicz-Zięba M.: Postępy w leczeniu zakażenia Clostridium difficile. Post. N. Med., 2014; 27: 770-775
  Google Scholar
• 11. Borody T.J.: “Flora power”-fecal bacteria cure chronic C. difficile diarrhea. Am. J. Gastroenterol., 2000; 95: 3028-3029
  Google Scholar
• 12. Borody T.J., Campbell J., Torres M., Nowak A, Leis S.: Reversal of idiopathic thrombocytopenic purpura (ITP) with fecal microbiota transplantation (FMT). Am. J. Gastroenterol., 2011; 106: S352
  Google Scholar
• 13. Borody T.J., George L., Andrews P., Brandl S., Noonan S., Cole P., Hyland L., Morgan A., Maysey J., Moore-Jones D.: Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med. J. Aust., 1989; 150: 604
  Google Scholar
• 14. Borody T.J., Leis S., Campbell J. I wsp.: Fecal microbiota transplantation (FMT) in multiple sclerosis (MS). Am. J. Gastroenterol., 2011; 106: S352
  Google Scholar
• 15. Borody T.J., Nowak A, Torres M., Campbell J., Finlayson S.L.: Bacteriotherapy in chronic fatigue syndrome: a retrospective review. Am. J. Gastroenterol., 2012; 107, Suppl. 1: S591-S592
  Google Scholar
• 16. Borody T.J., Paramsothy S., Agrawal G.: Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr. Gastroenterol. Rep., 2013; 15: 337
  Google Scholar
• 17. Borody T.J, Warren E.F., Leis S., Surace R., Ashman O.: Treatment of ulcerative colitis using fecal bacteriotherapy. J. Clin. Gastroenterol., 2003; 37: 42-47
  Google Scholar
• 18. Borody T.J., Warren E.F., Leis S., Surace R., Ashman O., Siarakas S.: Bacteriotherapy using fecal flora: toying with human motions. J. Clin. Gastroenterol., 2004; 38: 475-483
  Google Scholar
• 19. Borody T.J, Wettstein A., Campbell J., LeisS., Torres M., Finlayson S., Nowak A.: Fecal microbiota transplantation in ulcerative colitis: review of 24 years experience. Am. J. Gastroenterol., 2012; 107(S1): S665, Abstract 1644
  Google Scholar
• 20. Borody T.J., Wettstein A.R., Leis S., Hills L.A, Campbell J., Torres M.: Clostridium difficile complicating inflammatory bowel disease: pre – and post-treatment findings. Gastroenterology, 2008; 134: A361
  Google Scholar
• 21. Brandt L.J., Aroniadis O.C.: Long-term follow-up study of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). Am. J. Gastroenterol., 2012; 107: 1626: 657
  Google Scholar
• 22. Brandt L.J., Aroniadis O.C., Mellow M., Kanatzar A., Kelly C., Park T., Stollman N., Rohlke F., Surawicz C.: Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol., 2012; 107: 1079-1087
  Google Scholar
• 23. Cammarota G., Masucci L., Ianiro G. Bibbo S., Dinoi G., Costamagna G., Sanguinetti M., Gasbarrini A.: Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment. Pharmacol. Ther., 2015; 41: 835-843
  Google Scholar
• 24. DePestel D.D., Aronoff D.M.: Epidemiology of Clostridium difficile infection. J. Pharm. Pract., 2013; 26: 464-475
  Google Scholar
• 25. Di Bella S., Gouliouris T., Petrosillo N.: Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J. Infect. Chemother., 2015; 21: 230-237
  Google Scholar
• 26. Dubberke E.R., Haslam D.B., Lanzas C., Bobo L.D., Burnham C.A., Gröhn Y.T., Tarr P.I.: The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge. Zoonoses Public Health, 2011; 58: 4-20
  Google Scholar
• 27. Eiseman B., Silen W., Bascom G.S., Kauvar A.J.: Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 1958; 44: 854-859
  Google Scholar
• 28. Garborg K., Waagsbø B., Stallemo A., Matre J., Sundøy A.: Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand. J. Infect. Dis., 2010; 42: 857-861
  Google Scholar
• 29. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., Bergwerff A.A., Dekker F.W., Kuijper E.J: Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis., 2008, 47: 1162-1170
  Google Scholar
• 30. Gough E., Shaikh H., Manges A.R.: Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis., 2011; 53: 994-1002
  Google Scholar
• 31. Guo B., Harstall C., Louie T., Veldhuyzen van Zanten S., Dieleman L.A.: Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment. Pharmacol. Ther., 2012; 35: 867-875
  Google Scholar
• 32. Hamilton M.J., Weingarden A.R., Sadowsky M.J., Khoruts A.: Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am. J. Gastroenterol., 2012; 107: 761-767
  Google Scholar
• 33. Hensgens M.P., Keessen E.C., Squire M.M., Riley T.V., Koene M.G., de Boer E., Lipman L.J., Kuijper E.J.: European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD): Clostridium difficile infection in the community: a zoonotic disease? Clin. Microbiol. Infect., 2012; 18: 634-645
  Google Scholar
• 34. Jensen M.B., Olsen K.E., Nielsen X.C., Hoegh A.M., Dessau R.B., Atlung T., Engberg J.: Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture. Eur. J. Clin. Microbiol. Infect. Dis., 2015; 34: 727-736
  Google Scholar
• 35. Jones A.M., Kuijper E.J., Wilcox M.H.: Clostridium difficile: a European perspective. J. Infect., 2013; 66: 115-128
  Google Scholar
• 36. Kassam Z., Hundal R., Marshall J.K., Lee C.H.: Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch. Intern. Med., 2012; 172: 191-193
  Google Scholar
• 37. Kelly C.: Fecal microbiota transplantation – an old therapy comes of age. N. Engl. J. Med., 2013; 368: 474-475
  Google Scholar
• 38. Kelly C., Lamont J.: Clostridium difficile – more difficult than ever. N. Engl. J. Med., 2008; 359: 1932-1940
  Google Scholar
• 39. Khanna S., Pardi D.: Clostridium difficile infection: new insights into management. Mayo Clin. Proc., 2012; 87: 1106-1117
  Google Scholar
• 40. Khanna S., Pardi D.: The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev. Gastroenterol. Hepatol., 2010; 4: 409-416
  Google Scholar
• 41. Khoruts A., Dicksved J., Jansson J.K., Sadowsky M.J.: Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol., 2010; 44: 354-360
  Google Scholar
• 42. Kleger A., Schnell J., Essig A., Wagner M., Bommer M., Seufferlein T., Härter G.: Fecal transplant in refractory Clostridium difficile colitis. Dtsch. Arztebl. Int., 2013; 110: 108-115
  Google Scholar
• 43. Ley R.E.: Obesity and the human microbiome. Curr. Opin. Gastroenterol., 2010; 26: 5-11
  Google Scholar
• 44. Louie T.J., Cannon K., Byrne B., Emery J., Ward L., Eyben M., Krulicki W.: Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin. Infect. Dis., 2012; 55: 132-142
  Google Scholar
• 45. Lund B.M., Peck M.W.: A possible route for foodborne transmission of Clostridium difficile? Foodborne Pathog. Dis., 2015; 12: 177-182
  Google Scholar
• 46. Lund-Tønnesen S., Berstad A., Schreiner A., Midtvedt T.: Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr. Nor. Laegeforen., 1998; 118: 1027-1030
  Google Scholar
• 47. McCune V.L, Struthers J.K., Hawkey P.M.: Faecal transplantation for the treatment of Clostridium difficile infection: a review. Int. J. Antimicrob. Agents, 2014; 43: 201-206
  Google Scholar
• 48. Nagalingam N.A., Lynch S.V.: Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis., 2012; 18: 968-984
  Google Scholar
• 49. Oldfield IV E.C., Oldfield III E.C., Johnson D.A.: Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J. Gastrointest. Pharmacol. Ther., 2014; 5: 1-26
  Google Scholar
• 50. Pituch H., Bakker D., Kuijper E., Obuch-Woszczatyński P., Wultańska D., Nurzyńska G., Bielec A., Bar-Andziak E., Łuczak M.: First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland. Pol. J. Microbiol., 2008; 57: 267-268
  Google Scholar
• 51. Ray A., Smith R., Breaux J.: Fecal microbiota transplantation for Clostridium difficile infection: the ochsner experience. Ochsner J., 2014; 14: 538-544
  Google Scholar
• 52. Reddy S.S., Brandt L.J.: Clostridium difficile infection and inflammatory bowel disease. J. Clin. Gastroenterol., 2013; 47: 666-671
  Google Scholar
• 53. Rohlke F., Stollman N.: Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap. Adv. Gastroenterol., 2012; 5: 403-420
  Google Scholar
• 54. Rohlke F., Surawicz C.M., Stollman N.: Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J. Clin. Gastroenterol., 2010; 44: 567-570
  Google Scholar
• 55. Round J.L., Lee M., Li J., Tran G., Jabri B., Chatila T.A., Mazmanian S.K.: The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science, 2011; 332: 974-977
  Google Scholar
• 56. Round J.L., Mazmanian S.K.: Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA, 2010; 107: 12204-12209
  Google Scholar
• 57. Rupnik M., Songer J.G.: Clostridium difficile: its potential as a source of foodborne disease. Adv. Food Nutr. Res., 2010; 60: 53-66
  Google Scholar
• 58. Tannock G.W.: The bowel microbiota and inflammatory bowel diseases. Int. J. Inflam., 2010; 2010: 954051
  Google Scholar
• 59. Tannock G.W., Munro K., Taylor C., Lawley B., Young W., Byrne B., Emery J., Louie T.: A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology, 2010; 156: 3354-3359
  Google Scholar
• 60. van Nood E., Speelman P., Kuijper E.J., Keller J.J.: Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? EuroSurveill., 2009; 14: 19316
  Google Scholar
• 61. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., Speelman P., Dijkgraaf M.G., Keller J.J.: Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Eng. J. Med., 2013; 368: 407-415
  Google Scholar
• 62. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R.S., Bartelsman J.F., Dallinga-Thie G.M., Ackermans M.T., Serlie M.J., Oozeer R., Derrien M., Druesne A., Van Hylckama Vlieg J.E., Bloks V.W., Groen A.K.: Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology, 2012; 143: 913-916
  Google Scholar
• 63. Walia R., Kunde S., Mahajan L.: Fecal microbiota transplantation in the treatment of refractory Clostridium difficile infection in children: an update. Curr. Opin, Pediatr., 2014; 26: 573-578
  Google Scholar
• 64. Zanella Terrier M.C., Simonet M.L., Bichard P., Frossard J.L.: Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. World J. Gastroenterol., 2014; 20: 7416-7423
  Google Scholar
• 65. Zupancic M.L., Cantarel B.L., Liu Z., Drabek E.F., Ryan K.A., Cirimotich S., Jones C., Knight R., Walters W.A., Knights D., Mongodin E.F., Horenstein R.B., Mitchell B.D., Steinle N., Snitker S.: Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS One, 2012; 7: e43052
  Google Scholar

Full text